Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19

Схожие документы

• Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors
  по: DiNicolantonio, James J, et al.
  Опубликовано: (2021)
• Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections
  по: DiNicolantonio, James J, et al.
  Опубликовано: (2021)
• Correction: Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
  Опубликовано: (2020)
• Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase
  по: DiNicolantonio, James J, et al.
  Опубликовано: (2020)
• Azithromycin and glucosamine may amplify the type 1 interferon response to RNA viruses in a complementary fashion
  по: DiNicolantonio, James J., et al.
  Опубликовано: (2020)